Quantum computing in healthcare: unlocking the next frontier

For decades, advances in computing power have shaped the way healthcare is delivered. From early electronic records to today’s artificial intelligence, digital technology has steadily transformed diagnosis, treatment and research. Now, a new wave of innovation is on the horizon: quantum computing. With the potential to perform calculations far beyond the reach of even the most powerful supercomputers, quantum computing is being heralded as a breakthrough that could redefine the possibilities of modern medicine.

What is quantum computing?

Unlike classical computers, which store information in binary digits (bits) that are either 0 or 1, quantum computers use quantum bits, or qubits. Thanks to the principles of quantum mechanics, qubits can exist in multiple states at once. This allows quantum computers to perform vast numbers of calculations simultaneously, solving certain problems exponentially faster than conventional machines.

While the technology is still in its infancy, with practical quantum computers not yet widely available, researchers are already exploring how it could transform industries reliant on complex data – healthcare chief among them.

Accelerating drug discovery

One of the most promising applications of quantum computing lies in drug discovery. Developing a new medicine involves modelling how molecules interact inside the body, a task that quickly becomes too complex for classical computers. Quantum computers, with their ability to simulate molecular structures and interactions at an atomic level, could make this process far more accurate and efficient.

This could significantly shorten the time it takes to identify promising drug candidates. Instead of years of trial and error in the lab, researchers could use quantum-powered simulations to narrow down the most effective compounds before moving into clinical trials. For patients, this could mean faster access to new treatments for conditions ranging from cancer to rare genetic diseases.

Personalised medicine and genomics

Healthcare is moving towards increasingly personalised approaches, where treatments are tailored to the genetic and biological profile of each patient. Analysing the huge datasets generated by genomic sequencing and other “omics” fields is computationally demanding, but quantum computing could dramatically accelerate this process.

By processing vast amounts of genetic data more quickly and accurately, quantum systems could help identify the best treatment strategies for individual patients. For example, they could uncover subtle genetic variations that influence how a person responds to a particular drug, paving the way for more precise and effective care.

Transforming medical imaging

Medical imaging technologies such as MRI and CT scans generate huge amounts of data that need to be processed and interpreted. Quantum algorithms could potentially improve both the speed and accuracy of image reconstruction, enabling clinicians to detect diseases earlier and with greater confidence.

Beyond improving existing imaging methods, quantum computing could also open the door to entirely new approaches. By harnessing quantum principles, researchers are exploring ways to create more detailed images at the molecular level, which could revolutionise diagnostics.

Optimising healthcare systems

Quantum computing’s potential extends beyond direct patient care. Healthcare systems like the NHS face enormous challenges in managing resources, from scheduling operations to predicting demand for services. These are classic optimisation problems – areas where quantum algorithms could excel.

In theory, quantum computers could help design more efficient hospital logistics, reduce waiting times and allocate resources in ways that improve both patient outcomes and cost-effectiveness. For a health service under constant pressure, such efficiencies could prove transformative.

Challenges and uncertainties

Despite the potential, it is important to acknowledge that quantum computing in healthcare is still largely experimental. Building reliable quantum machines is technically daunting, and current systems remain limited in scale and stability. Many of the applications being discussed are still years away from practical deployment.

There are also ethical and regulatory considerations. For example, the ability to process genetic and health data at unprecedented speed raises questions about data security and patient privacy. Ensuring that the benefits of quantum healthcare are distributed fairly, rather than concentrated in wealthy countries or institutions, will be another challenge.

The UK’s position

The UK has been quick to recognise the importance of quantum technologies. Through its National Quantum Technologies Programme, the country is investing heavily in research and commercialisation, with healthcare identified as a priority sector. Collaborations between universities, the NHS and technology companies are already exploring early applications, laying the groundwork for future breakthroughs.

The UK’s strengths in life sciences, combined with its established expertise in AI and data-driven healthcare, mean it is well placed to be a leader in applying quantum computing to medicine. By fostering partnerships and investing in infrastructure, the country could ensure that patients benefit from these advances as soon as the technology matures.

Looking ahead

Quantum computing is not a replacement for classical computing or existing AI tools. Instead, it should be seen as a powerful addition to the healthcare innovation toolkit – one that could solve problems previously thought intractable. Whether it is discovering new drugs, tailoring treatments to individuals or managing health systems more effectively, the potential is vast.

Yet progress will depend on continued investment, close collaboration between science and medicine, and careful attention to the ethical implications. If these conditions are met, quantum computing could be one of the most significant developments in healthcare since the advent of modern computing itself.

Conclusion

Quantum computing in healthcare remains at an early stage, but its promise is undeniable. By unlocking new levels of processing power, it could accelerate discovery, enhance diagnosis and deliver more personalised patient care. For the UK, the opportunity is not only to harness this technology for domestic benefit but also to play a leading role in shaping its global future.

As the boundaries of medicine and technology continue to converge, quantum computing stands out as a frontier that could transform what is possible in healthcare. The challenge now is to ensure that this future is developed responsibly, equitably and with the needs of patients at its heart.

Author

Leave A Comment

Shabna Raja

Advisory Partner,
Life Sciences Week
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Shabna Raja is a senior leader in enterprise transformation within Life Sciences, with over 20 years’ experience spanning pharma, consumer health and large-scale digital programmes.

She specialises in bridging strategy and execution – helping organisations translate AI, data and digital innovation into tangible business outcomes. Her work focuses on complex transformation
initiatives across commercial, data and operating model domains within regulated environments.

Shabna spent seven years at GSK, where she played a key role in transformation programmes, including as part of the Consumer Health joint venture with Pfizer — one of the most significant integrations in the sector. This experience provided her with deep expertise in  organisational change, integration and operating model evolution at global scale.

More recently, she has spent over three years working closely with Haleon through a strategic
services partnership, leading enterprise client engagement and managing a multi-million-pound account while supporting transformation across a newly independent global organisation.

Her experience spans the end-to-end life sciences value chain, including R&D, commercial, supply chain and patient engagement, giving her a holistic perspective on how technology and transformation can unlock value across the industry.

Amjad Khan

Executive Partner,
Life Sciences Week
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Amjad Khan is a UK-based entrepreneur, AI strategist, and senior technology leader with over 15 years of experience at Pfizer, where he held multiple leadership roles across digital strategy and transformation. As Global Digital Client Partner, he was responsible for digital strategy and execution across Global Business Units covering Vaccines, Hospital, and Medical Affairs. Most notably, he led the commercial launch for the Covid franchise transforming and accelerating the model for how new medicines are brought to market.

Following his tenure at Pfizer, Amjad channelled his expertise into building at the frontier of AI. His work spans AI leadership, stakeholder engagement, and agile delivery helping organisations adopt
and scale emerging  technologies to drive meaningful outcomes.

Dr. Richard Fallon | Business Consultant | WM Life Sciences

Dr. Richard Fallon

Co Founder, Life Sciences Week 
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Dr Richard Fallon is an entrepreneur and ecosystem builder who connects industry leaders, investors and public-sector stakeholders to accelerate collaboration and commercial growth.

As the Founder of the Technology Supply Chain and co-founder of the Innovation Awards, he has spent more than two decades convening influential networks that help emerging businesses find capital, strategic partners and new routes to market.

Richard’s work spans leadership and consultancy across major organisations, alongside building membership and partnership platforms that bring universities, industry and investors into the same room – and turn conversations into practical outcomes.

With his focus on life sciences, Richard supports organisations and people driving breakthroughs in healthcare, biotechnology, medical technology and advanced research. He is passionate about creating the conditions for transformative ideas to move from concept to real-world impact – by connecting innovators with the funding, expertise and opportunities they need to scale.

Through Life Sciences Week, Richard is championing the UK’s world-class life sciences community and helping position it at the forefront of innovation, investment and patient outcomes.

Paul Cadman | Executive Chairman | WM Life Sciences

Prof Paul Cadman

CEO of One Thousand Trades Group & Co-founder of Life Sciences Week,
Life Sciences Week
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Prof. Paul Cadman is a nationally and internationally recognised, award-winning inclusive leader and “knowledge broker”, known for bringing people, ideas and organisations together to turn ambition into deliverable outcomes.

His experience spans Research, Technology, Manufacturing, Consultancy and Membership Organisations – giving him a rare ability to translate between sectors, priorities and professional cultures in a way that builds trust and unlocks progress.

Across his career, Paul has helped take concepts from inception through to scale, including initiatives that have generated £100m+ in turnover. He combines strategic thinking with an extensive network, supporting organisations to drive organic growth, forge partnerships and deliver meaningful business transformation. He is particularly valued for his ability to connect the right stakeholders at the right time, and create the conditions for collaboration to become action.

Through Life Sciences Week, Paul helps convene the communities shaping innovation – bringing together research, industry and investment to strengthen relationships, spotlight opportunity, and accelerate real-world impact.

Amy Deakin | Chief of Staff | WM Life Sciences

Amy Deakin

Event Managing Director,
Life Sciences Week
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Amy Deakin is a Birmingham-based leader specialising in building partnerships and fostering innovation in the life sciences sector. With a degree in Sport and Exercise Science, Amy brings a grounded understanding of human health and performance to her work and a strong interest in the developments shaping healthcare today.

Amy is Managing Director of Life Sciences Week, part of the One Thousand Trades Group, and also serves as Director of One Thousand Trades Events. In these roles, she convenes researchers, clinicians and industry leaders to strengthen collaboration, unlock new partnerships and help accelerate real-world innovation across the life sciences ecosystem.

Her career spans both commercial and third-sector environments. She began in automotive design, delivering projects for Volkswagen, McLaren, Bentley and Jaguar Land Rover, before moving into the third sector with Acorns Children’s Hospice. She later joined Western Union, working as a Partnerships Manager for international payments

An avid netballer, Amy is a committed advocate for health and wellbeing – bringing energy, clarity and connection to everything she builds, and actively involved as a participant in health related research studies.

    Award Category Voting

    Here's a list of all categories you can vote for. Simply click each category to cast your vote. Voting in each category is not mandatory, so please feel free to click just the category that interests you.

    Day you've not voted in, will be denoted with an ❌

    If you're having issues submitting the form, please ensure all the category boxes are closed and try again.

    Recognising pioneering research, technology, or therapies that are transforming healthcare and biotechnology.

    No VoteProf. Alex RichterBlack Space TechnologyAston Vision Sciences

    Celebrating an emerging leader making significant contributions to the field through research, innovation, or leadership.

    Recognising pioneering research, technology, or therapies that are transforming healthcare and biotechnology.

    No VoteShashank Chaganty – VichagLeah Vanono - PBS InnovationsKloe Avon- KZ Organics

    Honouring successful cross-sector partnerships driving advancements in life sciences, from academia to industry.

    No VoteProf Liam Grover- WMHTIAJudith Stewart- Health Innovation West MidlandsAdam McGuinness - Plug and Play

    Awarding an individual or organisation for exceptional long-term impact on the industry.

    No VoteDavid KidneyMedilink MidlandsUniversity of Birmingham

    Highlighting innovations in treatments, diagnostics, or healthcare delivery that have significantly improved patient outcomes.

    No VoteJean-Louis Duprey - Linear DiagnosticsSian Dunning - MD-TECKarim Vissangy - HoloMedix

    Your Details